Key Points
- Tenet Healthcare director J Robert Kerrey sold 5,638 shares on May 28 at an average price of $174.52, generating about $983,944 and reducing his ownership by 25.12%.
- Tenet reported strong quarterly results, with EPS of $4.82 beating estimates of $4.21, while revenue reached $5.37 billion, slightly below expectations but up 2.6% year over year.
- Analysts remain mostly positive on the stock, with 19 Buy ratings and 3 Hold ratings; the average target price is $244.16 despite some recent target cuts.
Tenet Healthcare Corporation (NYSE:THC - Get Free Report) Director J Robert Kerrey sold 5,638 shares of the firm's stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director owned 16,804 shares of the company's stock, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Tenet Healthcare Price Performance
Shares of THC opened at $174.83 on Friday. Tenet Healthcare Corporation has a 1-year low of $146.60 and a 1-year high of $247.21. The stock has a market cap of $15.06 billion, a PE ratio of 9.09, a P/E/G ratio of 1.14 and a beta of 1.30. The firm has a 50-day simple moving average of $189.94 and a two-hundred day simple moving average of $201.87. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.
Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts' consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion during the quarter, compared to analysts' expectations of $5.39 billion. During the same period last year, the business earned $4.36 earnings per share. The business's revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, analysts forecast that Tenet Healthcare Corporation will post 17.67 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Triumph Capital Management purchased a new position in Tenet Healthcare in the third quarter worth approximately $25,000. Activest Wealth Management purchased a new position in Tenet Healthcare in the fourth quarter worth approximately $26,000. Elyxium Wealth LLC purchased a new position in Tenet Healthcare in the fourth quarter worth approximately $29,000. Westside Investment Management Inc. lifted its stake in Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company's stock worth $39,000 after acquiring an additional 96 shares during the last quarter. Finally, Meeder Asset Management Inc. raised its holdings in Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company's stock worth $38,000 after purchasing an additional 114 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on the stock. Barclays dropped their price target on shares of Tenet Healthcare from $257.00 to $238.00 and set an "overweight" rating for the company in a research report on Tuesday, May 5th. Truist Financial lifted their price target on shares of Tenet Healthcare from $240.00 to $270.00 and gave the company a "buy" rating in a research report on Tuesday, February 17th. Leerink Partners raised their price objective on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an "outperform" rating in a research note on Friday, February 20th. Wall Street Zen lowered shares of Tenet Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Monday, May 11th. Finally, Wells Fargo & Company lowered their price objective on shares of Tenet Healthcare from $265.00 to $213.00 and set an "overweight" rating for the company in a research note on Friday, May 1st. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, Tenet Healthcare has an average rating of "Moderate Buy" and an average target price of $244.16.
Get Our Latest Research Report on THC
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
